Myelofibrosis secondary to renal osteodystrophy

Nephron

Volumn 72, Issue 4, 1996, Pages 683-687

  Nomura, Shinsuke ^a   Ogawa, Youji ^a   Osawa, Gengo ^a   Katagiri, Makoto ^b   Harada, Tanekazu ^b   Nagahana, Haruki ^c  

^a Kawasaki Medical School   (Japan)

^b KAWASAKI MEDICAL SCHOOL   (Japan)

^c Shigei Hospital   (Japan)

Author keywords

Hyperparathyroidism; Myelofibrosis; Recombinant human erythropoietin; Renal osteodystrophy

Indexed keywords

ADULT; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW BIOPSY; BONE MARROW SCINTISCANNING; CASE REPORT; EXTRAMEDULLARY HEMATOPOIESIS; FEMALE; HEMATOCRIT; HEMODIALYSIS; HUMAN; HUMAN TISSUE; MYELOFIBROSIS; MYELOPHTHISIC ANEMIA; PARATHYROIDECTOMY; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; SECONDARY HYPERPARATHYROIDISM; SPLENOMEGALY;

ALKALINE PHOSPHATASE; BONE MARROW; FEMALE; HEMATOCRIT; HUMANS; MIDDLE AGED; MYELOFIBROSIS; PARATHYROID GLANDS; PARATHYROID HORMONE; PARATHYROIDECTOMY; RENAL OSTEODYSTROPHY; TRANSPLANTATION, AUTOLOGOUS;

EID: 0029924224     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188961     Document Type: Article

References (16)

1. Athens JW: Myelofibrosis; in Lee GR. Bithell TC. Focrster J. Athens JW. Lukens JN (eds): Wintrobe's Clinical Hematology. Philadelphia. Lea & Febigcr. 1993.pp 2018-2033.
2. Polasman I. Better OS: The role of secondary hyperparathyroidism in the anemia of chronic renal failure. Nephron 1983:33:229-231.
3. Drucke TB: Modulating factors in the hematopoietic response to erythropoietin. Am J Kidney Dis 1991:18:87-92.
4. Smith RE. Chelmowski MK. Szabo EJ: Myelofibrosis: A concise review of clinical and pathologic features and treatment. Am J Hcmalol 1988;29:174-180.
5. Weinberg SG. Lubin A. Wiener SN, Deoras MP. Ghose MK, Kopelman RC: Myelofibrosis and renal osteodystrophy. Am J Med 1977;63: 755-764.
6. Hunter D: Hyperparathyroidism: Generalized osteitis fibrosa. Br J Surg 1931:19:203-284.
7. Zingral TJ. Drucke T. Marie P. Man NK. Jüngers P, Bordier P: Anemia and secondary hyperparathyroidism. Arch Intern Med 1978; 138:1650-1652.
8. Barbour GL: Effect of parathyroidectomy on anemia in chronic renal failure. Arch Intern Med 1979;139:889-891.
9. Nomura S, Osawa G, Karai M: Treatment of a patient with end-stage renal disease, severe iron overload and ascites by weekly phlebotomy combined with recombinant human erythropoietin. Nephron 1990:55:210-213.
10. Delwiche F, Garrity MJ. Powell JS, Robertson RP, Adamson JW: High levels of the circulating form of parathyroid hormone do not inhibit in vitro crythropoicsis. J Lab Clin Med 1983; 102:613-620.
11. McGonigle RJ. Wallin JD, Husserl F, Deftos U. Rice JC, O’Neill WJ. Fisher JW: Potential role of parathyroid hormone as an inhibitor of crythropoiesis in the anemia of renal failure. J Lab Clin Med 1984;104:1016-1026.
12. Drueke TB: Resistance to recombinant human erythropoietin in hemodialysis patients. Am J Nephrol 1990;2:34-39.
13. Rao DS, Shih MS. Mohini R: Effect of serum parathyroid hormone and bone marrow fibrosis on the response to crythropictin in uremia (see comments). N Engl J Med 1993:328:171-175.
14. Boxer M. Ellman L. Geller R, Wang C-A: Anemia in primary hyperparathyroidism. Arch Intern Med 1977;137:588-590.
15. Shasha SM, Better OS. Winavcr J, Chaimovitz C. Barzilai A. Erlik D: Improvement in the anemia of hemodialyzed patients following subtotal parathyroidectomy. Israel J Med Sei 1978; 14:328-332.
16. Ishimura J, Fukuchi M: Scintigraphic evaluation of secondary myelofibrosis associated with prostatic cancer before and after hormone therapy. Clin Nucl Med 1990;15:330-333.